Cargando…
Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
Diabetes mellitus (DM) is an alarming metabolic disease in which insulin secreting β-cells are damaged to various extent. Unfortunately, although currently available treatments help to manage the disease, however, patients usually develop complications, as well as decreased life quality and increase...
Autores principales: | Kamal, Mohamed M., Kassem, Dina H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000356/ https://www.ncbi.nlm.nih.gov/pubmed/32064260 http://dx.doi.org/10.3389/fcell.2020.00016 |
Ejemplares similares
-
Wharton’s jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications
por: Drobiova, Hana, et al.
Publicado: (2023) -
Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis
por: Kassem, Dina H., et al.
Publicado: (2020) -
Human Wharton’s Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways
por: Joerger-Messerli, Marianne S., et al.
Publicado: (2021) -
Human Wharton’s Jelly Stem Cell Secretions Inhibit Human Leukemic Cell Line K562 in vitro by Inducing Cell Cycle Arrest and Apoptosis
por: Huwaikem, Muneerah A. H., et al.
Publicado: (2021) -
The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)